![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development
PCI Pharma Services Print Issue November 2018 Drug Research
In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under increasing pressure to expedite the development of new therapies,to decrease...
Capitalizing on Digital Innovation to Enhance Delivery
Johnson & Johnson Print Issue November 2018 Packaging & Labelling
The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You?
Janssen Supply Chain Vice President Remo Colarusso explains how the company is pioneering high-tech new strategies to perfect...
How implementing electronic clinical outcome assessments (eCOA) into Oncology Clinical Trials Reduces the Burden...
CRF Bracket Print Issue November 2018 Clinical Trials
Clinical oncology research is unique when compared to other therapeutic areas. Cancer patients experience substantial physical and psychosocial consequences of the disease and its treatment and much of the symptom burden occurs outside the...
Predicting the future of cancer immunotherapy: Using autoantibody biomarkers to drive safer and more...
Protagen AG Online Topics Drug Research
For a number of years now, immunotherapy has been seen as the dawn of a new era, and is the most promising approach to cancer treatment since the use of targeted therapies, making headlines...
The Pharmacist Perspective: Medication Adherence & Compliance
Progressive Care Inc Online Topics Packaging & Labelling
Adherence generally refers to taking a medication as prescribed which includes maintaining the proper dosing schedule throughout the medication cycle as well as continuing to take a medication for as long as the treatment...
Three Important Factors for Selecting a Reliable Serialization Software
rfxcel – Track and Trace Software Online Topics Packaging & Labelling
The WHO estimates that roughly 10% of drugs in the global marketplace are counterfeit, with levels being much higher in developing countries (30-40%).
In the U.S. alone, the FDA found that more than 50% of...
DSCSA one-month countdown
Online Topics Drug Research
From 27 November 2018, the Drug Supply Chain Security Act (DSCSA) will be actively enforced by regulators in the US. Here, leaders from across the pharmaceutical sector discuss the industry’s readiness...
Is the market now DSCSA ready?
Online Topics Drug Research
Roundtable questionsIn November 2017, the pharma industry was granted an extension of the Drug Supply Chain Security Act (DSCSA) enforcement date to November 2018. Regulators told the market that they would not actively enforce...
35 is the danger zone for hearts
Online Topics IT & Data Management
We normally associate heart disease with old age. Doctors have been warning that the average age of first heart attacks has been coming down due to multiple factors like sedentary lifestyles, fast food and...
DSCSA: The time has come to Act
Videojet Technologies Online Topics Packaging & Labelling
Thierry Protas, Global Pharma Director at Videojet Technologies, looks at the importance of the Drug Supply Chain Security Act (DSCSA) legislation, the looming 2018 cut off point for compliance, and how coding and marking...